TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biotechst Lund AB
Closing information (x1000 DKK)
| Closing information | 2023/08 | 2022/08 | 2021/08 |
| Turnover |
411
|
560
|
512 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-65
|
51
|
8 |
| EBITDA |
-65
|
51
|
8 |
| Total assets |
215
|
351
|
322 |
| Current assets |
215
|
351
|
322 |
| Current liabilities |
69
|
118
|
124 |
| Equity capital |
146
|
233
|
198 |
| - share capital |
63
|
70
|
73 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/08 | 2022/08 | 2021/08 |
| Solvency |
67.9%
|
66.4%
|
61.5% |
| Turnover per employee |
411
|
560
|
512 |
| Profit as a percentage of turnover |
-15.8%
|
9.1%
|
1.6% |
| Return on assets (ROA) |
-30.2%
|
14.5%
|
2.5% |
| Current ratio |
311.6%
|
297.5%
|
259.7% |
| Return on equity (ROE) |
-44.5%
|
21.9%
|
4.0% |
| Change turnover |
-95
|
73
|
-5 |
| Change turnover % |
-19%
|
15%
|
-1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/08 | 2022/08 | 2021/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.